-
公开(公告)号:AT90672T
公开(公告)日:1993-07-15
申请号:AT89113380
申请日:1989-07-21
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , VON PHILIPSBORN GERDA DR
IPC: C07D209/08 , A61K31/135 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/415 , A61K31/445 , A61K31/495 , A61P9/06 , C07C217/22 , C07D207/32 , C07D207/323 , C07D207/333 , C07D209/12 , C07D231/12 , C07D295/08 , C07D295/092 , C07D333/22
-
公开(公告)号:DE4117904A1
公开(公告)日:1992-12-03
申请号:DE4117904
申请日:1991-05-31
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , SCHULT SABINE DR , BEHL BERTHOLD DR , KIRCHENGAST MICHAEL DR
IPC: C07D211/26 , C07D211/56 , C07D211/58 , C07D401/04
Abstract: Substituted N-phenylpiperidines I (* CHEMICAL STRUCTURE *) I (R1=H, NO2, CN, halogen, C1-C4-alkyl, CF3, OCF3, OH, CH2OH, COOH, CHO, NH-CHO, NH2, CO-NH2, 5-tetrazinyl, R4-O-, R4-O-CH2-, R4O-CO-, R4-CO-, R4-NH-CO, R4-CO-NH-, R4-SO2-NH-; R2=H, NO2, halogen, C1-C4-alkyl or R4-O-; (* CHEMICAL STRUCTURE *) (* CHEMICAL STRUCTURE *) (* CHEMICAL STRUCTURE *) (* CHEMICAL STRUCTURE *) (* CHEMICAL STRUCTURE *) R4=C1-C4-alkyl or phenyl which can carry one of the R2 radicals; R5, R6=H or one of the R4 radicals; R7 =one of the R1 radicals; n=0 or 1; m=1 or 2; with the proviso that R3 is (* CHEMICAL STRUCTURE *) only when n is 1, and the optical isomers in the case of optical isomerism, and the physiologically tolerated acid addition salts, are suitable as drugs.
-
公开(公告)号:DE4032767A1
公开(公告)日:1992-04-30
申请号:DE4032767
申请日:1990-10-16
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , SCHULT SABINE DR , BINDER RUDOLF DR , RASCHACK MANFRED DR , REINHARDT ROLAND DR , SEEMANN DIETMAR DR
IPC: A61K31/445 , A61K31/4468 , A61P9/00 , C07D211/58
Abstract: Phenylpiperidinylamines of the formula I I where R1 is -NHSO2R4 or R2 and R3 are each, independently of one another, H or C1-C4-alkyl or together are a (CH2)n chain with n=4 or 5, and R4 is C1-C4-alkyl or phenyl, and the physiologically tolerated salts thereof, and pharmaceutical compositions containing these are described.
-
公开(公告)号:MY128488A
公开(公告)日:2007-02-28
申请号:MYPI9905192
申请日:1999-11-27
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , KOCK MICHAEL DR , GER THOMAS H XD DR , SCHULT SABINE DR , GRANDEL ROLAND DR , MUELLER REINHOLD DR
IPC: A61P9/00 , A61K20060101 , A61K31/4184 , A61K31/454 , A61K31/496 , A61P20060101 , A61P3/12 , A61P9/10 , A61P13/12 , A61P17/02 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P43/00 , C07D20060101 , C07D235/30 , C07D401/04 , C07D401/14 , C07D403/04
Abstract: COMPOUNDS OF THE FORMULA IA OR IB(FORMULA)WHERE R1 IS HYDROGEN OR BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, WHERE ONE CARBON ATOM OF THE ALKYL RADICAL MAY FURTHERMORE CARRY OR5 (WHERE R5 IS HYDROGEN OR C1-C4-ALKYL), OR ONE CARBON ATOM IN THE CHAIN MAY ALSO CARRY AN =O GROUP OR A GROUP NR8R9, WHERE R8 AND R9, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR8R9 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE CARBON CHAINS IN R8 OR R9 OR THE RING FORMED BY NR8R9 MAY FURTHERMORE CARRY A RADICAL R6 WHICH, INDEPENDENTLY OF R2, MAY HAVE THE SAME MEANING AS R2,R4 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, CHLORINE, BROMINE, FLUORINE, NITRO, CYANO, NR8R9, NH-CO-R10 OR OR8, WHERE R8 AND R9, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR8R9 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE RING MAY FURTHERMORE CARRY A RADICAL (BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, CO-R41, COOR41 OR PHENYL), AND R10 MAY BE HYDROGEN, C1-C4-ALKYL OR PHENYL AND R41 MAY HAVE THE SAME MEANINGS AS R21,A IS A SATURATED OR MONOUNSATURATED HETEROCYCLIC, 4- TO 8-MEMBERED RING WHICH CONTAINS ONE OR TWO NITROGEN ATOMS, IT BEING POSSIBLE FOR AN OXYGEN OR SULFUR ATOM ADDITIONALLY TO BE INCORPORATED, WHICH OXYGEN OR SULFUR ATOM IS SUBSTITUTED BY R2 AND R3, WHERER2 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C8-ALKYL WHICH MAY FURTHERMORE BE SUBSTITUTED BY R23, AND A CARBON ATOM OF THE CHAIN MAY CARRY AN =O GROUP, C3-C7-CYCLOALKYL-C1-C4-ALKYL,-CO-(NH)0,l-R2l, COOR2l OR PHENYL, WHERE R21 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL,C3-C7-CYCLOALKYL-C1-C4-ALKYL, PHEN-C1-C4-ALKYL, C3-C7-CYCLOALKYL OR PHENYL, AND EACH RADICAL MAY FURTHERMORE CARRY (CH2)0-2-R23, AND THE RESPECTIVE PHENYL RING IN TURN MAY FURTHERMORE BE SUBSTITUTED BY 1, 2 OR 3 OF THE FOLLOWING RADICALS: CHLORINE, FLUORINE, BROMINE, IODINE, BRANCHED ANDSTRAIGHT-CHAIN C1-C4-ALKYL, NITRO, CF3, CYANO, -(CH2)0-2,NR24R25, NH-CO-R10, OR10, COOR10, SO2-C1-C4-ALKYL, SO2PH, SO2NH, NHSO2-C1-C4-ALKYL, NHSO2PH AND CF3, WHERE R24 AND R25, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR24R25 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE RING MAY FURTHERMORE CARRY A RADICAL OF BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, CO-R22, COOR22 (WHERE R22 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, PHENYL-C1-C4-ALKYL, C3-C7-CYCLOALKYL OR PHENYL) OR PHENYL, AND R10 IS HYDROGEN, C1-C4-ALKYL OR PHENYL, ANDR23 IS NR26R27 WHERE R26 AND R27 ARE EACH HYDROGEN, C1-C6-ALKYL, C0-C4-ALKYLPHENYL, WHERE THE PHENYL RING MAY FURTHERMORE BE SUBSTITUTED BY UP TO 3 RADICALS C1, F, BR, I, C1-C4-ALKYL, CF3, CN, SO2-C1-C4-ALKYL, SO2-PHENYL, NO2, NH2, NHCO-C1-C4-ALKYL, NHCO-PHENYL, OH, O-C1-C4-ALKYL, O-C1-C4-ALKYLPHENYL, AND NR26R27 MAY ALSO BE A CYCLIC AMINE HAVING 3 TO 8 MEMBERS, WHERE A FURTHER HETERO ATOM SUCH AS O, N AND S MAY ALSO ADDITIONA1LY BE PRESENT, AND THE RING MAY FURTHERMORE BE SUBSTITUTED BY A RADICAL R28 WHERE R28 MAY BE C1-C4-ALKYL AND C1-C4-ALKYLPHENYL,R3 IS HYDROGEN, BRANCHED OR STRAIGHT-CHAIN C1-C8-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL WHICH IS UNSUBSTITUTED OR SUBSTITUTED BY C1-C6-ALKYL OR C3-C7-CYCLOALKYL WHICH IS UNSUBSTITUTED OR SUBSTITUTED BY C1-C6-ALKYL, WHERE ONE CARBON ATOM OF THE RADICAL MAY FURTHERMORE CARRY A PHENYL RING WHICH IN TURN MAY ALSO BE SUBSTITUTED BY 1,2 OR 3 OF THE FOLLOWING RADICALS: CHLORINE, FLUORINE, BROMINE, IODINE, BRANCHED AND STRAIGHT-CHAIN C1-C4-ALKYL, NITRO, CF3, CYANO, (CH2)0-2, NR32R33, NH-CO-R10, OR10, COOR10, SO2-C1-C4-ALKYL, SO2PH, CH3, SO2NH, NHSO2-C1-C4-ALKYL, NHSO2PH AND CF3, WHERE R32 AND R33, INDEPENDENTLY OF ONE ANOTHER, ARE EACH HYDROGEN OR C1-C4-ALKYL AND NR32R33 TOGETHER MAY BE A CYCLIC AMINE HAVING 4 TO 8 RING ATOMS, WHERE THE RING MAY FURTHERMORE CARRY A RADICAL OF BRANCHED OR STRAIGHT-CHAIN C1-C6-ALKYL, C3-C7-CYCLOALKYL-C1-C4-ALKYL, CO-R31, COOR31 OR PHENYL, AND R10 IS HYDROGEN, C1-C4-ALKYL OR PHENYL, AND R31 MAY HAVE THE SAME MEANING AS R21,AND THEIR TAUTOMERIC FORMS, POSSIBLE ENANTIOMERIC AND DIASTEREOMERIC FORMS, THEIR PRODRUGS AND POSSIBLE PHYSIOLOGICALLY TOLERATED SALTS.
-
公开(公告)号:HU0004648A2
公开(公告)日:2001-05-28
申请号:HU0004648
申请日:1998-10-05
Applicant: BASF AG
Inventor: BACH ALFRED DR , DULLWEBER UTA , EMLING FRANZ DR , GARCIA-LADONA XAVIER , LUBISCH WILFRIED DR , STARCK DOROTHEA , STEINER GERD DR , TESCHENDORF HANS-JUERGEN DR , WICKE KARSTEN DR
IPC: A61K31/519 , A61P1/00 , A61P1/14 , A61P3/04 , A61P5/00 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D471/00 , C07D471/04
Abstract: 3-substituted tetrahydropyridopyrimidinone derivatives of the formula (I) wherein the radicals have the meanings given in the Description, to a method for producing said derivatives and, to their use for producing active ingredients for drugs.
-
公开(公告)号:CZ20003891A3
公开(公告)日:2001-03-14
申请号:CZ20003891
申请日:1999-04-20
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , MOELLER ACHIM DR , TREIBER HANS-JOERG DR , KNOPP MONIKA DR
IPC: A61K31/44 , A61K31/455 , A61K31/495 , A61K31/505 , A61P25/28 , C07D213/82 , C07D215/50 , C07D239/42 , C07D295/155 , C07D317/60 , C07D401/04 , C07D405/12
-
公开(公告)号:DE59309070D1
公开(公告)日:1998-11-26
申请号:DE59309070
申请日:1993-05-17
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , BEHL BERTHOLD DR , HOFMANN HANS PETER DR
IPC: A61K31/495 , A61K31/498 , A61P25/00 , A61P25/08 , A61P25/20 , A61P25/22 , A61P25/24 , A61P25/26 , C07D241/44 , C07D241/52 , C07D401/04 , C07D403/04 , C07D487/12 , C07D487/14
Abstract: Quinoxaline-2,3-(1H,4H)diones of the general formula I in which the variables have the following meaning: R is hydrogen; an aliphatic radical having up to 12 C atoms, which can carry one of the following substituents: phenyl, cyclopentyl, cyclohexyl or a group -CO-R , -CO-O-R or -CO-NH-R , where R denotes hydrogen, C1-C4-alkyl, phenyl, benzyl or 1-phenylethyl; a cycloaliphatic radical having up to 12 C atoms, or a phenyl group, where the cyclic groups contained in R can carry up to three of the following substituents: C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, halogen, nitro, cyano, -CO-O-R and -CO-NH-R ; R is a pyrrol-1-yl group which can carry up to two of the following substituents: C1-C4-alkyl, phenyl, phenylsulphonyl, nitro, cyano and one of the groups -CO-O-R , -CO-NH-R , -CH2-O-R , -O-R and -CH=NO-R ; R is identical or different radicals from the following: C1-C4-alkyl, C1-C4-alkoxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, trichloromethoxy, fluorine, chlorine, bromine, iodine, nitro, cyano and one of the groups -CO-O-R and -CO-NH-R and a fused benzene ring; n is 0 to 3. Quinoxaline-2,3-(1H,4H)diones I' in which R has the meaning mentioned. The compounds I and I' are suitable as medicines for human and veterinary medicine.
-
公开(公告)号:DE19642591A1
公开(公告)日:1998-04-16
申请号:DE19642591
申请日:1996-10-15
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , MOELLER ACHIM DR , DELZER JUERGEN DR
IPC: A61K31/445 , A61K31/4523 , A61K31/4545 , A61K31/4709 , A61K31/498 , A61K31/5355 , A61P9/10 , A61P25/14 , A61P25/28 , A61P35/00 , A61P43/00 , C07D211/62 , C07D213/40 , C07D295/04 , C07D401/06 , C07D401/12 , C07D401/14 , C07D409/06 , C07D413/12 , C07D413/14
Abstract: Disclosed are piperidine-keto acid derivates of general formula (I) and their tautomeric and isomeric forms, as well as their physiologically well tolerated salts, where R can mean -CO-R , -SO -R , -CONH-R , -COOR , -C(=N)-R , -C(=O)-NHR and -C(=S)-NHR ; R can have the meaning -C1-C6-alkyl, whether branched or not, and can still carry a phenyl, a pyridine or a naphthyl-ring, which can possibly be substituted with no more than two R residues, while R C1-C4-alkyl, whether branched or not, can mean -O-C1-C4-alkyl, OH, Cl, F, Br, J, CF3, NO2, NH2, CN, COOH, COO-C1-C4-alkyl, -NHCO-C1-C4-alkyl, -NHCOPh, -NHSO2-C1-C4-alkyl, NHSO2-Ph, -SO2-C1-C4-alkyl and -SO2Ph; and R can mean -OR and -NHR . The preparation of the inventive compounds and their use as drug products are also disclosed.
-
公开(公告)号:CZ9701131A3
公开(公告)日:1998-03-18
申请号:CZ113197
申请日:1995-10-02
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , VIERLING MICHAEL , BEHL BERTHOLD DR , HOFMANN HANS PETER DR
IPC: A61K31/495 , A61P25/00 , A61P43/00 , C07D403/04
CPC classification number: C07D403/04
-
公开(公告)号:DE4436852A1
公开(公告)日:1996-04-18
申请号:DE4436852
申请日:1994-10-14
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , VIERLING MICHAEL , BEHL BERTHOLD DR , HOFMANN HANS-PETER DR
IPC: A61K31/495 , A61P25/00 , A61P43/00 , C07D403/04 , C07D403/14
Abstract: Pyrrolyl-tetrahydrobenzoquinoxaline diones having the formula (I) are disclosed, as well as their tautomeric and isomeric forms, their physiologically compatible salts and their preparation. In the formula, the variables have the meanings given in the description. These new compounds are glutamate antagonists useful in the therapy of neurodegenerative diseases.
-
-
-
-
-
-
-
-
-